Venous thromboembolism, comprising both Deep Venous Thrombosis and
Pulmonary Embolism, is a chronic illness. VTE is an important cause of
postoperative morbidity and mortality, especially when patients with co-morbid
conditions (like obesity, coronary artery disease, or cancer) are on the rise.
This necessitates the use of various thromboprophylaxis measures to prevent the
occurrence of fatal VTE. However, the pharmacological thromboprophylaxis
carries an inherent risk of bleeding, especially when the area of invasive work
involves a potential space with a risk of non-compressible arterial puncture.
During neuraxial anaesthesia, such bleeding into a closed space can result in
spinal hematoma, which carries various neurological sequelae and requires
urgent diagnosis and management.
The aim of the study is to review and analyse the relevant
literature on the modalities of thromboprophylaxis, their mechanism of action
and optimal management of such patients in the perioperative setting. In the
perioperative setting, managing a patient on thromboprophylaxis therapy is
still challenging, and with the introduction of various newer anticoagulants,
management becomes more perplexing. In view of limited randomised trials
pertaining to the thromboprophylaxis management in regional anaesthesia
settings, a thorough knowledge of the mechanism and duration of action of these
anticoagulant drugs, as well as recommended guidelines, is essential for the
effective management of such patients.
Author(s)
Details
Ragi
Jain
Department of Anesthesia, Santosh Medical and Dental College and
Hospital, Ghaziabad (Uttar Pradesh), India.
Please
see the book here:- https://doi.org/10.9734/bpi/msraa/v7/5736
No comments:
Post a Comment